Indanorex

This classification denotes an anorexiant with the molecular formula C12H17NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 982LOO7DEE, chemically known as 1h-inden-2-ol, 2-(1-aminopropyl)-2,3-dihydro- but more generally known as indanorex, which bears US NIH Compound Identifier 65623. European Medicines Agency schedules Indanorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08168MIG. The term INDANOREX is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 28, No. 10 1974, List 14). INDANOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule indanorex under HS 29221980 and SITC 51461. As of Q4 2014, INDANOREX remains US FDA's Preferred Term for this commodity. Indanorex bears US NLM identifiers UMLS ID C2827198 and NCI Concept Code C83795. SMILES: CCC(C1(CC2=CC=CC=C2C1)O)N.